Intravenous Metoprolol Dosing for Rate Control in Atrial Fibrillation
For a hemodynamically stable patient with intermittent non-sustaining atrial fibrillation, systolic BP >100 mmHg, HR >100 bpm, and no contraindications, administer IV metoprolol 5 mg over 1-2 minutes, repeated every 5 minutes as needed up to a maximum total dose of 15 mg. 1
Dosing Algorithm
Initial dose: 5 mg IV push over 1-2 minutes
Reassess after 5 minutes:
- If HR remains >100 bpm and patient tolerates initial dose → give second 5 mg dose over 1-2 minutes
- If HR controlled (<100 bpm) → stop and monitor
Reassess after another 5 minutes:
- If HR still >100 bpm after second dose → give third 5 mg dose over 1-2 minutes
- Maximum total dose: 15 mg 1
Monitoring Requirements
During IV administration, continuously monitor:
- Blood pressure (watch for hypotension)
- Heart rate (watch for excessive bradycardia)
- Electrocardiogram 1, 2
Key Evidence and Considerations
The 2010 AHA ACLS Guidelines provide the definitive dosing regimen for IV metoprolol in atrial fibrillation: 5 mg over 1-2 minutes, repeated as required every 5 minutes to a maximum dose of 15 mg 1. This recommendation carries Class I, Level of Evidence B designation for controlling ventricular rate in patients with atrial fibrillation 3.
The 2024 ACC/AHA/HRS Guidelines reaffirm this approach, specifying 2.5-5 mg IV bolus over 2 minutes, up to 3 doses for metoprolol tartrate 4, 5. The FDA-approved labeling for metoprolol injection confirms this dosing strategy 2.
Important caveats:
- Avoid in patients with asthma, obstructive airway disease, decompensated heart failure, or pre-excited atrial fibrillation 1
- Side effects include hypotension, bradycardia, and potential precipitation of heart failure 1
- Metoprolol is a β1-specific blocker with negative inotropic effects 1
Comparative Effectiveness
Recent meta-analyses suggest diltiazem may achieve rate control more effectively than metoprolol (OR 1.92 for achieving rate control target) 6, with faster time to rate control 7, 6. However, both agents demonstrate similar safety profiles regarding hypotension and bradycardia 8, 6, 9. The choice between agents should consider that most comparative studies used flat-dose metoprolol versus weight-based diltiazem, potentially biasing results 10.
For patients already on chronic β-blocker therapy, metoprolol is less effective—only 42.4% achieve rate control versus 56.1% in β-blocker-naive patients 11. In such cases, consider diltiazem as first-line or use higher cumulative metoprolol doses.
Transition to Oral Therapy
If the patient tolerates the full IV dose and achieves rate control, transition to oral metoprolol tartrate 25-50 mg every 6 hours initially, then adjust to maintenance dosing of 25-200 mg twice daily based on response 5, 2.